Navigation Links
Marken Validates Top Position in Global Clinical Sample Shipments
Date:3/15/2012

PARIS, March 15, 2012 /PRNewswire/ --  Marken is pleased to share its year-end data which validates that it holds a market-leading position in the shipment of in-bound biological samples to the major central laboratories and to Pharma directly.  In the past 18 months, Marken collected shipments from over 49,000 clinical investigators in 159 countries around the world.  An independent survey* conducted by a major consulting group, confirms that Marken has more than 60% of the specialty courier market in biological samples transportation, and a higher share of the cold chain segment of that same market. Marken also commissioned an in-depth market research study in 2011 with The Avoca Group.  The Avoca Group interviewed over 100 individuals, including current clients, from 74 global pharmaceutical, CRO, laboratory, and sponsor companies who use supply chain services. In the survey, Marken achieved the top score when asked "Who do you consider a leader in clinical trial logistics?"  The qualities attributed to Marken's leading position were cost effectiveness, flexibility, on-time performance and customer service. Marken intends to conduct this survey annually as a means to monitor and improve its client service position.

(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

With its recent expansion in India and continued growth in Asia, Marken continues to broaden its reach and existing outbound shipments for the pharmaceutical industry which will include: drug product shipments, patient kit shipments, active pharmaceutical ingredients (API) shipments and medical devices.  To support the growing demand, Marken has accelerated its development of pharmaceutical service depots in Asia, Europe, North America and Latin America whilst ensuring that the stringent Quality and Performance criteria of the temperature controlled supply chain are met.

"We are pleased to share the 2011 results from our independent research. The growth in biologics and the increasing need for temperature controlled supply chain will encourage more of our clients to use Marken for their time and temperature sensitive shipments," said Wes Wheeler, Marken's CEO.  "We are experts in worldwide collection of patient samples which is derived from the personal visits we make to 49,000 clinical investigators in 159 countries. We have leveraged this expertise to our growing outbound business as well and will continue to expand our reach with new locations and new distribution services in the life science industries."

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.

*Survey Study Funded by Marken


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Opens New Corporate Offices
2. Marken Strengthens Clinical Trial Distribution Capabilities
3. Marken Appoints New Head of Global Quality Assurance
4. Marken Announces Its New Logistics Operating System: Maestro™
5. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
6. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
7. Marken Rapidly Responds to Global Supply Chain Security Measures
8. Marken Unveils New Japan Office
9. New Research Validates Results of Previous Studies Demonstrating Tru-D® (Lumalier Corporation) Significantly Reduces Environmental Contamination on Surfaces in Patient Rooms
10. Study Validates Clinical Accuracy of 50% Dose Reduction for Positron Emission Mammography
11. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... 27, 2017  Sanderling Ventures, portfolio company, Torax ... division of Johnson & Johnson. Torax manufactures and markets ... of gastro-esophageal reflux disease (GERD). The LINK device ... and the procedure is currently available in the ... Medical was founded by Sanderling Ventures, Mayo Medical ...
(Date:3/27/2017)... AVIV, Israel , March 27, 2017 ... on oncology and immunology, announced today that AGI-134, an immunotherapy ... announced acquisition of Agalimmune Ltd., will be featured at the ... in Washington, DC to be ... ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Thank you ... Diego on February 8-10. , This event was exclusive to providers and offered ... , The meeting took place at the Manchester Grand Hyatt where attendees gathered for ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Bacteria and fungi are probably not the first ... bad. In fact, including the right microorganisms in your diet can actually improve health outcomes. ... , This is the topic of a new peer-reviewed paper led by ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. ... smile makeovers without requiring a referral. Trimble Dental offers a variety of ... dentistry and dental implants. Whether patients have discolored, crooked or missing teeth in ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... site attention and engagement over the household brands of Top-20 pharma by optimizing ... discuss how partnering with the right outsourcing payments provider can provide the technology, ...
(Date:3/27/2017)... Reston, VA (PRWEB) , ... March 27, 2017 ... ... mobile application containerization, today announced it will co-exhibit with technology partners LG Business ... held at the Marriott Metro Center in Washington D.C., will provide education and ...
Breaking Medicine News(10 mins):